Targeted Therapies in Oncology
December 1, 2021
Volume: 10
Issue: 7
December 2, 2021
Volume: 10
Issue: 18
November 1, 2021
Volume: 1
Issue: 1
October 2, 2021
Volume: 10
Issue: 14
October 1, 2021
Volume: 10
Issue: 13
September 2021
Volume: 10
Issue: 12
August 2021
Volume: 10
Issue: 11
July 1 2021
Volume: 10
Issue: 9
July 2 2021
Volume: 10
Issue: 10
June 2021
Volume: 10
Issue: 8
May 2021
Volume: 10
Issue: 7
April 2, 2021
Volume: 10
Issue: 6
April 1, 2021
Volume: 10
Issue: 5
March 2021
February 2, 2021
Volume: 10
Issue: 3
February 1, 2021
Volume: 10
Issue: 2
January 2021
Volume: 10
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
5